Cutaneous T-cell-attracting chemokine as a novel biomarker for predicting prognosis of idiopathic pulmonary fibrosis: a prospective observational study.

Takafumi NiwamotoTomohiro HandaYuko MuraseYoshinari NakatsukaKiminobu TanizawaYoshio TaguchiHiromi TomiokaKeisuke TomiiHideo KitaMichihiro UyamaMichiko TsuchiyaMasahito EmuraTetsuji KawamuraNaoki AraiMachiko AritaKazuko UnoAkihiko YoshizawaRyuji UozumiIzumi YamaguchiFumihiko MatsudaKazuo ChinToyohiro Hirai

Published in: Respiratory research (2021)

CTACK is a novel prognostic biomarker of IPF. Trial registration None (because of no healthcare intervention).

Keyphrases

idiopathic pulmonary fibrosis
healthcare
interstitial lung disease
randomized controlled trial
study protocol
clinical trial
phase iii
phase ii
rheumatoid arthritis
systemic sclerosis
health information